Scilex Holding Co (SCLX) stock

SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$1.56−0.06 (-3.70%)

Close on Nov 12, 2026Market cap $13.25MP/E –Yield –

Scilex statistics

69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Jun 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $13.25M; $280.48M
Enterprise Value: $91.32M; $148.62M
PS Ratio: 0.42; 3.60

Enterprise valuationIndustry

EV / Sales: 2.89; 2.60

Share statisticsIndustry

Shares Outstanding: 8M; 58M
Shares Change (QoQ): -17.2%; 0.48%
Shares Held by Institutions: 9.81%; 56.4%

Short sellingIndustry

Short Interest: 132,205; –
Short Interest Change: -10.9%; -0.76%
Days to Cover: 3.37; 5.13

Stock price statisticsIndustry

52-Week High: $27.00; –
52-Week Low: $1.54; –
20-Day Moving Average: $2.06; –
50-Day Moving Average: $3.48; –
200-Day Moving Average: $6.47; –
Average True Range (14): $0.20; –
Price Change (1 Week): -8.24%; 1.51%
Price Change (1 Month): -45.3%; -2.37%
Price Change (3 Months): -76.9%; -21.1%
Price Change (6 Months): -76.0%; -22.8%
Price Change (YTD): -87.2%; -22.6%
Price Change (1 Year): -91.7%; -21.0%
Price Change (3 Years): -96.5%; -24.8%
Price Change (5 Years): -99.6%; -76.9%
Average Volume (10 Days): 40,664; –
Average Volume (20 Days): 39,506; –
Average Volume (90 Days): 50,284; –
Relative Volume: 0.95; 0.80
Relative Strength Index (14): 14.4; 44.7
Volatility (1 Year): 99.4%; 80.2%
Beta (5 Years): 0.81; 1.07

MarginsIndustry

Gross Margin: 161.1%; 53.0%
Operating Margin: -1136.4%; -38.5%
Pretax Margin: -1469.7%; -11.8%
Profit Margin: -1469.8%; -31.7%
EBITDA Margin: -1110.1%; -27.7%

Returns on capitalIndustry

Return on Assets (ROA): -275.4%; -40.7%

Financial positionIndustry

Current Ratio: 0.07; 3.31
Quick Ratio: 0.01; 2.41
Interest Coverage: -22.20; -6.35

GrowthIndustry

Revenue Growth (YoY): -28.5%; 7.26%
Revenue Growth (3Y CAGR): -7.35%; 2.25%
Revenue Growth (5Y CAGR): 5.13%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.19; 0.40
Inventory Turnover: 4.21; 2.73
Revenue Per Employee: $929.65K; $429.38K
Profits Per Employee: -$13.66M; -$683.67K
Employee Count: 34; 75
WACC: 11.4%; 10.0%

Income statement (TTM)Industry

Revenue: $31.61M; $66.69M
Gross Profit: $50.91M; $116.10M
Operating Income: -$359.19M; -$20.99M
Pretax Income: -$464.55M; -$13.23M
Net Income: -$464.56M; -$21.61M
EBITDA: -$350.88M; -$16.85M

Balance sheetIndustry

Cash & Short-Term Investments: $566.00K; $67.18M
Total Debt: $80.81M; $116.91M
Net Cash (Debt): -$80.24M; $16.98M
Net Cash Per Share: -$9.45; $0.72
Equity (Book Value): -$308.32M; $52.68M
Book Value Per Share: -$36.30; $1.50
Tangible Book Value: -$379.41M; $26.74M
Working Capital: -$476.01M; $78.52M

Cash flow (TTM)Industry

Operating Cash Flow: -$17.09M; -$12.27M

Dividends and yieldsIndustry

Earnings Yield: -3506.4%; -21.0%

Taxes and interestIndustry

Interest Expense: $16.18M; $2.97M

Scores and fair valueIndustry

Altman Z-Score: -12.74; 0.26
Piotroski F-Score: 4; 4
Beneish M-Score: -7.50; -2.62

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	SCLX	S&P 500	Difference	SCLX per year	S&P 500 per year
1 month	-44.3%	-2.7%	−41.6 pts
3 months	-77.4%	-1.7%	−75.6 pts
Year to date	-79.5%	+11.9%	−91.4 pts
1 year	-86.8%	+12.0%	−98.7 pts
3 years	-94.5%	+78.2%	−172.6 pts	-61.9%	+21.2%
5 years	-99.3%	+73.2%	−172.5 pts	-62.8%	+11.6%
10 years	-99.1%	+309.6%	−408.8 pts	-37.6%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M SCLX shares were sold short on Oct 30, 2026, down 10.9% from the previous report. At recent volumes it would take 3.4 days to buy them back. Over the last 20 sessions, 42.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	132,205	-10.9%	39,269	3.4
Oct 15, 2026	148,382	-13.3%	56,400	2.6
Sep 30, 2026	171,151	-3.1%	29,690	5.8
Sep 15, 2026	176,711	+11.2%	29,995	5.9
Aug 31, 2026	158,922	+4.2%	51,317	3.1
Aug 14, 2026	152,585	-13.1%	38,579	4.0
Jul 31, 2026	175,537	-16.1%	97,056	1.8
Jul 15, 2026	209,224	+27.6%	298,601	1.0
Jun 30, 2026	163,989	-19.2%	91,395	1.8
Jun 15, 2026	203,080	-11.3%	74,375	2.7
May 29, 2026	229,014	+45.0%	128,480	1.8
May 15, 2026	157,966	-6.6%	119,163	1.3